RxDoctor Payments Data

Douglas Stoinski

Podiatrist · Howell, MINPI 1427315753

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.2% of the total across 83 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Kerecis Limited at 29.8% of the total. 2025 is the largest year on record at $2,338, more than ten times the $200 reported in 2019. Among podiatrist clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$8,529in general payments, 2019–2025

Across 83 payments — averaging $102.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Kerecis Limited$3K
  • Acumed LLC$2K
  • Osteomed LLC$1K
  • Organogenesis Inc.$754
  • Integra Lifesciences Corporation$717
  • Treace Medical Concepts, Inc.$516
  • plus $1K from 8 others

What the payments were for

  • Food & beverage$7,94693%
  • Education$5837%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,529 in reported general payments places this provider in the 90th percentile of 302 podiatrist providers in Michigan.

See all podiatrist providers in Michigan

Medicare billing

Part B allowed, 2024
$75,945
Medicare patients
352
Services billed
1,025

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Econazole Nitrate23$369
Terbinafine Hcl15$192
Doxycycline Monohydrate11$101

Paid to pharmacies, not to this prescriber.

Other podiatrist in Howell

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →